GR3032891T3 - Signal transmission and tag power consumption measurement circuit for an inductive reader. - Google Patents

Signal transmission and tag power consumption measurement circuit for an inductive reader.

Info

Publication number
GR3032891T3
GR3032891T3 GR20000400586T GR20000400586T GR3032891T3 GR 3032891 T3 GR3032891 T3 GR 3032891T3 GR 20000400586 T GR20000400586 T GR 20000400586T GR 20000400586 T GR20000400586 T GR 20000400586T GR 3032891 T3 GR3032891 T3 GR 3032891T3
Authority
GR
Greece
Prior art keywords
power consumption
signal transmission
measurement circuit
consumption measurement
tag power
Prior art date
Application number
GR20000400586T
Other languages
English (en)
Inventor
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL103052A external-priority patent/IL103052A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of GR3032891T3 publication Critical patent/GR3032891T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GR20000400586T 1992-09-03 2000-03-07 Signal transmission and tag power consumption measurement circuit for an inductive reader. GR3032891T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL103052A IL103052A (en) 1992-09-03 1992-09-03 Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
GR3032891T3 true GR3032891T3 (en) 2000-07-31

Family

ID=26322502

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400586T GR3032891T3 (en) 1992-09-03 2000-03-07 Signal transmission and tag power consumption measurement circuit for an inductive reader.

Country Status (11)

Country Link
EP (1) EP0588177B1 (el)
JP (3) JP3662264B2 (el)
AT (1) ATE189262T1 (el)
AU (1) AU674523B2 (el)
CA (1) CA2105449C (el)
DE (1) DE69327693T2 (el)
DK (1) DK0588177T3 (el)
ES (1) ES2142840T3 (el)
GR (1) GR3032891T3 (el)
IL (1) IL106591A (el)
PT (1) PT588177E (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
EP0859633A2 (en) * 1996-08-16 1998-08-26 Kurt B. Osther Method for treating diabetes
WO1998008099A1 (en) * 1996-08-19 1998-02-26 SHAKER, Ghassan, I. Use of molt4 cd69 expression to determine the presence and activity of interferon inhibitors
DE69805844T2 (de) 1997-12-19 2002-10-24 Applied Research Systems Ifnnar/ifn komplex
EP1893646A2 (en) * 2005-06-22 2008-03-05 Genentech, Inc. Methods and compositions for targeting ifnar2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88377A (en) * 1988-11-14 1996-09-12 Yeda Res & Dev Cloning and expression of a protein which modulates cellular response to type I interferon
FR2657881A1 (fr) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.

Also Published As

Publication number Publication date
EP0588177A3 (en) 1994-08-17
PT588177E (pt) 2000-05-31
ES2142840T3 (es) 2000-05-01
DE69327693T2 (de) 2000-09-07
DE69327693D1 (de) 2000-03-02
JP3907661B2 (ja) 2007-04-18
DK0588177T3 (da) 2000-05-08
ATE189262T1 (de) 2000-02-15
CA2105449C (en) 2010-07-20
JP3662264B2 (ja) 2005-06-22
AU4609693A (en) 1994-03-10
IL106591A0 (en) 1993-12-08
JP2005162762A (ja) 2005-06-23
JP2004254695A (ja) 2004-09-16
AU674523B2 (en) 1997-01-02
IL106591A (en) 2008-03-20
JPH06220100A (ja) 1994-08-09
EP0588177B1 (en) 2000-01-26
EP0588177A2 (en) 1994-03-23
CA2105449A1 (en) 1994-03-04

Similar Documents

Publication Publication Date Title
GB9405311D0 (en) Point-of-sale terminals
EP0417648A3 (en) Ic card
EP0417887A3 (en) Ic card
GB8919231D0 (en) Ic card
EP0412545A3 (en) Ic package and ic card incorporating the same thereinto
GB9316915D0 (en) Signal receiving coil and non-contact type ic card using the same
EP0603187A4 (en) Human lactoferrin.
GB2238901A (en) Magnetic card
AU2502992A (en) Electronic animal identification system
AU6888891A (en) Micromagnetic circuit
DE225431T1 (de) Pufferschaltung zur kompensierung des millerstromes.
GR3032891T3 (en) Signal transmission and tag power consumption measurement circuit for an inductive reader.
DE58908705D1 (de) Schaltungsanordnung zur Produktsummenberechnung.
AU2245688A (en) Card reader
AU1283992A (en) Integrated circuit card
GB8925692D0 (en) Identification circuit
GB2279907B (en) An integrated circuit card
SG91794G (en) Protein hydrolysis.
DE3676233D1 (de) Ansteuerschaltung fuer einen induktiven sensor.
DE3880338T2 (de) Schaltung zur konturkompensation.
GB2280348B (en) Processing low value animal products
GB2267682B (en) An integrated circuit card
HK67396A (en) Integrated limiting circuit for ac-voltages
AU6524190A (en) Document reader
EP0625821A3 (de) Schaltungsanordnung für eine induktive Last.